Zbigniew Żuber

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Fabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto et al. · New England Journal of Medicine · 2012 · 873 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber et al. · Annals of the Rheumatic Diseases · 2014 · 314 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

Gerd Horneff, Rubén Burgos‐Vargas, Tamás Constantin et al. · Annals of the Rheumatic Diseases · 2013 · 137 citations · Full text

Life Sciences, Genetics, Microbiology +17

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study

Nicolino Ruperto, Hermine I. Brunner, Zbigniew Żuber et al. · Pediatric Rheumatology · 2017 · 97 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

Hermine I. Brunner, Ivan Foeldvari, Nuray Aktay Ayaz et al. · Annals of the Rheumatic Diseases · 2022 · 77 citations · Full text

Medicine, Immunology, Pharmacotherapy +15